Abstract: Septic arthritis is a serious problem in the neonate, with a poor prognosis being reported for recovery. The impact of neonatal septic arthritis on the likelihood that Thoroughbred (TB) foals will start on a racecourse is not known. Objective: The development of septic arthritis in a TB foal significantly reduces the likelihood that it will race when compared to foals from the same dam. Methods: Medical records of 69 foals treated for septic arthritis were reviewed. The dam's foaling records were reviewed and lifetime racing records were then retrieved for both the affected foals and at least one of their siblings (controls). Outcomes that were statistically evaluated included discharge from the hospital and whether the foal eventually raced. Univariate analyses of categorical variables were conducted for each outcome. The number of affected and unaffected foals that raced at least once were compared using regression analysis. Survival analysis was used to compare age at first race between the study and comparison groups. Results: Foals with septic arthritis were less likely to start on a racecourse compared to controls (odds ratio [OR] 0.28; 95% confidence interval [CI] 0.12-0.62, P = 0.001), while those foals that were discharged from the hospital were also less likely to start on a racecourse compared to controls (OR 036; CI 0.15-0.83, P = 0.008). The presence of multisystem disease was associated with a decreased likelihood of surviving to be discharged (OR 0.13; 95% CI 0.02-0.90; P = 0.005), but did not affect the likelihood that they would start in at least one race if discharged successfully (OR 0.45; 95% CI 0.04-2.81; P = 0.34) compared to the other foals with septic arthritis. Log-rank comparison of survival curves confirmed that foals discharged following treatment for septic arthritis took significantly longer to start in their first race compared to the sibling population (mean age of study group 1757 days, CI 1604-1909; mean age of sibling group 1273 days, CI 1197-1349; P = 0.0006). Conclusions: The development of septic arthritis in a TB foal significantly reduces the likelihood that it will start on a racecourse when compared to controls. Conclusions: Accurate figures allowing a realistic assessment of the athletic future of a foal following treatment for septic arthritis are of significance for both owner and treating veterinarian.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The study reveals that Thoroughbred foals that develop septic arthritis, a serious neonatal condition, are significantly less likely to ever participate in a race compared to their siblings that do not contract the disease.
Methodology
The research examined the medical records of 69 foals that had been treated for septic arthritis. For comparison, it also included the records of at least one sibling (also classified as thoroughbreds) of each affected foal.
Study parameters included whether foals were discharged from the hospital after their treatment and if they eventually raced.
The analysis included individual evaluations of each categorical variable for every outcome.
Usage of regression analysis was employed to compare the number of foals that raced at least once, both affected and unaffected with septic arthritis.
Survival analysis was used to contrast the age at which the first race was started by the foals in the study and comparison groups.
Results
The research found that foals with septic arthritis were significantly less likely to start on a racecourse as compared to their unaffected siblings (odds ratio [OR] 0.28; 95% confidence interval [CI] 0.12-0.62, P = 0.001).
The affected foals that were discharged from the hospital were also notably less likely to begin racing compared to unaffected ones (OR 036; CI 0.15-0.83, P = 0.008).
The presence of multisystem disease decreased the probability of survival for discharge (OR 0.13; 95% CI 0.02-0.90; P = 0.005), but did not affect the likelihood of racing at least once upon successful discharge (OR 0.45; 95% CI 0.04-2.81; P = 0.34).
The research noted that foals discharged after treatment for septic arthritis took a significantly longer time to start in their first race compared to their unaffected siblings (P = 0.0006).
Conclusions
Septic arthritis significantly decreases the likelihood of a Thoroughbred foal starting on a racecourse.
Accurate predictions about the racing prospects of a foal following treatment for septic arthritis are critical for both the horse’s owner and treating veterinarian.
Cite This Article
APA
Smith LJ, Marr CM, Payne RJ, Stoneham SJ, Reid SW.
(2004).
What is the likelihood that Thoroughbred foals treated for septic arthritis will race?
Equine Vet J, 36(5), 452-456.
https://doi.org/10.2746/0425164044868396